1. Home
  2. NXT vs KRYS Comparison

NXT vs KRYS Comparison

Compare NXT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NXT

Nextracker Inc.

HOLD

Current Price

$92.69

Market Cap

13.2B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$245.78

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXT
KRYS
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
6.3B
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
NXT
KRYS
Price
$92.69
$245.78
Analyst Decision
Buy
Strong Buy
Analyst Count
21
9
Target Price
$91.80
$214.22
AVG Volume (30 Days)
1.7M
306.6K
Earning Date
01-27-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
275.72
EPS
3.85
6.66
Revenue
$3,373,226,000.00
$373,164,000.00
Revenue This Year
$17.53
$36.14
Revenue Next Year
$11.36
$41.80
P/E Ratio
$24.08
$37.06
Revenue Growth
20.37
54.51
52 Week Low
$36.06
$122.80
52 Week High
$112.74
$265.92

Technical Indicators

Market Signals
Indicator
NXT
KRYS
Relative Strength Index (RSI) 55.00 60.92
Support Level $86.64 $231.69
Resistance Level $92.90 $256.00
Average True Range (ATR) 3.99 6.63
MACD 0.23 -1.14
Stochastic Oscillator 73.81 53.92

Price Performance

Historical Comparison
NXT
KRYS

About NXT Nextracker Inc.

Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: